User:Mr. Ibrahem/Eslicarbazepine acetate

Eslicarbazepine acetate (ESL), sold under the brand names Aptiom and Zebinix among others, is a medication used to treat epilepsy with focal-onset seizures. It is taken by mouth. It may be used along or with other anti seizure medications.

Common side effects include dizziness, sleepiness, nausea, headache, double vision, tiredness, poor coordination, blurry vision, and tremor. Other side effects may include suicide, anaphylaxis, low sodium, and liver problems. Safety in pregnancy is unclear. It is a prodrug to (S)-(+)-licarbazepine, similarly to oxcarbazepine; and is beleived to work by inhibiting sodium channels.

Eslicarbazepine acetate was approved for medical use in Europe in 2009 and the United States in 2013. In the United Kingdom a dose of 400 mg per day for a month costs the NHS about £68 as of 2021. In the United States this amount costs about 1,050 USD.